Loading...

PE anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_PE_090808.jpg
C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
  • 1A8_PE_090808.jpg
    C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
127607 50 µg 108€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127608 200 µg 227€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Christian DA, et al. 2022. Sci Immunol. 7:eabq7432. PubMed
  2. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  3. Matter AL, et al. 2022. J Immunol. 209:1880. PubMed
  4. Mizutani T, et al. 2023. iScience. 26:106081. PubMed
  5. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  6. Zhu S, et al. 2023. J Nanobiotechnology. 21:81. PubMed
  7. Chung JY, et al. 2023. Nat Commun. 14:1794. PubMed
  8. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  9. Cozzolino M, et al. 2023. Int J Mol Sci. 24:. PubMed
  10. Kase N, et al. 2023. Front Cell Dev Biol. 11:1022081. PubMed
  11. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  12. Roy S, et al. 2023. J Clin Invest. 133:. PubMed
  13. Wang, S., Ye, G., et al. 2025. Gut. 75(1),81-93. PubMed
  14. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  15. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  16. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  17. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  18. Bowling S, et al. 2020. Cell. 181(6):1410-1422.e27. PubMed
  19. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  20. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  21. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  22. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  23. Volmari A, et al. 2021. Hepatol Commun. 5:2104. PubMed
  24. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  25. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  26. MacLean AJ, et al. 2022. Immunity. 55:718. PubMed
  27. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  28. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  29. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  30. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  31. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  32. Hopke A, et al. 2022. iScience. 25:105226. PubMed
  33. Nagre N, et al. 2022. Respir Res. 23:326. PubMed
  34. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  35. Wang Y, et al. 2023. FASEB J. 37:e22776. PubMed
  36. Pinto NA, et al. 2023. Cell Death Differ. :. PubMed
  37. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  38. He Y, et al. 2023. Nat Commun. 14:691. PubMed
  39. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  40. De Giovanni M, et al. 2022. Cell. 185:815. PubMed
  41. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  42. Kraynak CA, et al. 2022. Int J Pharm. 618:121634. PubMed
  43. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  44. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  45. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  46. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  47. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  48. Cai B, et al. 2016. Proc Natl Acad Sci U S A. 113: 6526 - 6531. PubMed
  49. Kozik J, et al. 2016. Sci Rep. 6:28556. PubMed
  50. Herz J, et al. 2015. J Exp Med. 212: 1153 - 1169. PubMed
  51. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  52. Gawish R, et al. 2022. Elife. 11:. PubMed
  53. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  54. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  55. Ancey PB, et al. 2021. Cancer Res. 81:2345. PubMed
  56. Machata S, et al. 2021. Front Immunol. 11:565869. PubMed
  57. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  58. Jung J, et al. 2019. Cell Host Microbe. 25:513. PubMed
  59. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  60. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  61. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  62. Ajendra J, et al. 2016. Sci Rep. 6:39648. PubMed
  63. Bottek J, et al. 2020. Mucosal Immunol. 1.029166667. PubMed
  64. Sharma K, et al. 2021. Cell Reports. 36(3):109351. PubMed
  65. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  66. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  67. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  68. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  69. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  70. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  71. Putnam NE, et al. 2019. PLoS Pathog. 15:e1007744. PubMed
  72. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  73. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  74. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
  75. Sun P, et al. 2015. J Hepatol. . PubMed
  76. Okada M, et al. 2014. J Biol Chem. 289:32926. PubMed
  77. Muhammad W, et al. 2022. Acta Biomater. 148:258. PubMed
  78. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  79. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  80. Ishii T,et al. 2017. Sci Rep.. 10.1038/s41598-017-12513-1. PubMed
  81. Xie D, et al. 2017. PLoS One. 10.1371/journal.pone.0181454. PubMed
  82. Harding M, et al. 2014. PLoS Pathog. 10:1004379. PubMed
  83. Morales D, et al. 2015. J Virol. 89:337. PubMed
  84. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  85. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  86. Yeo WS, et al. 2020. J Bacteriol. 202:00:00. PubMed
  87. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  88. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  89. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  90. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  91. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  92. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  93. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  94. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  95. Lemon J, et al. 2015. Infect Immun . 83: 3204-3212. PubMed
  96. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  97. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  98. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  99. Zhou Z, et al. 2019. Oxid Med Cell Longev. 2019:1209307. PubMed
  100. Metzger D, et al. 2015. J Infect Dis. 212: 445-452. PubMed
  101. Winkler MJ, et al. 2020. Basic Res Cardiol. 115:67. PubMed
  102. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  103. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  104. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  105. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  106. Zhang J, et al. 2022. iScience. 25:104963. PubMed
  107. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  108. Schaffert A, et al. 2020. Front Immunol. 10:3024. PubMed
  109. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  110. Qiu Z, et al. 2016. Sci Rep. 6:31936. PubMed
  111. Kojo K, et al. 2016. Sci Rep. 6:29650. PubMed
  112. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  113. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  114. Al Mamun A, et al. 2019. Neurochem Int. 127:148. PubMed
  115. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  116. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  117. McLaughlin PA et al. 2019. PLoS Pathog. 15(7):e1007847 . PubMed
  118. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  119. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  120. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  121. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  122. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  123. Catani J, et al. 2016. Transl Oncol. 9:565-574. PubMed
  124. Zhou Z, et al. 2022. Life (Basel). 12:. PubMed
  125. Baik JE, et al. 2022. Clin Transl Med. 12:e758. PubMed
  126. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  127. Markman JL, et al. 2020. Nat Commun. 11:1613. PubMed
  128. Wheeler MA, et al. 2019. Cell. 176:581. PubMed
  129. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  130. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  131. Umeshappa CS, et al. 2021. Cell Reports. 34(13):108919. PubMed
  132. Abe M, et al. 2020. Clin Exp Immunol. 303:199. PubMed
  133. Cosentino K, et al. 2022. Mol Cell. 82:933. PubMed
  134. Su M, et al. 2022. Nat Cardiovasc Res. 1:732. PubMed
  135. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  136. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  137. Unudurthi SD, et al. 2020. Life Sci. 117440:247. PubMed
  138. Finsterbusch M, et al. 2014. J Exp Med. 211:1307. PubMed
  139. Vergadi E, et al. 2014. J Immunol. 192:394. PubMed
  140. Rynkiewicz NK, et al. 2020. Sci Signal. 13:. PubMed
  141. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  142. Sanmarco LM, et al. 2021. Nature. 590:473. PubMed
  143. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  144. Tapia-Abellán A, et al. 2021. Sci Adv. 7:eabf4468. PubMed
  145. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  146. Kim Y, et al. 2012. J Immunol. 188:4226. PubMed
  147. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  148. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  149. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  150. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  151. Takizawa S, et al. 2022. Mol Med. 28:91. PubMed
  152. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  153. Kimura H, et al. 2019. Sci Rep. 9:5887. PubMed
  154. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  155. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  156. Bronisz–Budzynska I, et al. 2019. Skelet Muscle. 9:22. PubMed
  157. Wang G, et al. 2021. Cell Host Microbe. 29(5):777-791.e6. PubMed
  158. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  159. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  160. Murray MP, et al. 2022. Cell Rep. 38:110209. PubMed
  161. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  162. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  163. Penke LR, et al. 2020. Life Sci Alliance. 3:. PubMed
  164. Kim M, et al. 2018. Immunity. 49:151. PubMed
  165. Petkevicius K, et al. 2019. Elife. 8:e47990. PubMed
  166. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  167. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  168. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  169. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  170. Eislmayr K, et al. 2022. Sci Adv. 8:eabj7293. PubMed
  171. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  172. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  173. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  174. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  175. Vaibhav K, et al. 2020. Sci Adv. 6:eaax8847. PubMed
  176. Huang W, et al. 2016. Cell Death Differ. 10.1038/cdd.2016.115. PubMed
  177. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  178. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  179. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  180. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  181. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  182. Issah Y, et al. 2021. Elife. 10:. PubMed
  183. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  184. Buerfent BC, et al. 2019. GMS Infect Dis. 7:Doc04. PubMed
  185. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  186. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  187. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  188. Kimura T, et al. 2014. Int Immunol. 26:697. PubMed
  189. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  190. Hu R, et al. 2015. J Immunol. 195: 4802 - 4809. PubMed
  191. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  192. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  193. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  194. Subramaniam N, et al. 2021. Blood Adv. 5:1259. PubMed
  195. Li Y, et al. 2022. Theranostics. 12:5364. PubMed
  196. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  197. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  198. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  199. Weckbach LT, et al. 2019. J Exp Med. 216:350. PubMed
  200. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  201. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  202. Guo H, et al. 2016. J Immunol. 196: 2300 - 2308. PubMed
  203. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  204. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  205. Li Y, et al. 2020. Theranostics. 10:11376. PubMed
  206. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  207. Moraes JA, et al. 2018. J Innate Immun. 11:330. PubMed
  208. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  209. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  210. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  211. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  212. Hou Y, et al. 2013. J Nutr Biochem. 24:1555. PubMed
  213. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  214. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  215. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  216. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  217. Schuran FA, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  218. Wheeler MA, et al. 2020. Nature. 578:593. PubMed
  219. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  220. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  221. Zha ZX, et al. 2022. Acta Pharmacol Sin. :. PubMed
  222. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  223. Wang C, et al. 2020. Mucosal Immunol. 13:22. PubMed
  224. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  225. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  226. Rodgers M, et al. 2014. J Exp Med. 211:1333. PubMed
  227. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
  228. Qu J, et al. 2021. Int J Biol Sci. 17:2756. PubMed
  229. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  230. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  231. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  232. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
RRID
AB_1186104 (BioLegend Cat. No. 127607)
AB_1186099 (BioLegend Cat. No. 127608)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Spark Red™ 718 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
Spark Blue™ 574 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
PerCP/Fire™ 806 anti-mouse Ly-6G 1A8 FC
StarBright UltraViolet 575 anti-mouse Ly-6G 1A8 FC
Spark PLUS YG581™ anti-mouse Ly-6G 1A8 FC
Go To Top Version: 3    Revision Date: 01/06/2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account